RayzeBio inc (DELISTED) (RYZB:DL)
62.49
0.00 (0.00%)
USD |
NASDAQ |
Mar 06, 16:00
RayzeBio Accounts Payable (Quarterly): 2.237M for Sept. 30, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 2.237M |
| June 30, 2023 | 2.433M |
| Date | Value |
|---|---|
| December 31, 2022 | 2.623M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.237M
Minimum
Sep 2023
2.623M
Maximum
Dec 2022
2.431M
Average
2.433M
Median
Jun 2023
Accounts Payable (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 3.539B |
| Karuna Therapeutics Inc (DELISTED) | 6.783M |
| Ambrx Biopharma Inc (DELISTED) | 5.141M |
| Pfizer Inc | 5.591B |
| Mirati Therapeutics Inc (DELISTED) | 37.96M |